ALAMEDA, CA – May 17, 2017 – AllCells, LLC, a leading provider of hematologic tissue, primary cell types & services for life science research, and further manufacturing of cell therapies, today announced that it has expanded its Leadership Team with the addition of three highly experienced executives in the areas of Science & Technology, Enterprise Systems & Information Technology, and Accounting & Finance.
Timothy C. Fong, Ph.D joins the leadership team as Vice President, Science & Technology. With more than 20 years of biotech industry experience in cellular immunology and hematopoietic stem cells, Dr. Fong has led teams in discovery research, preclinical studies, product characterization, and GMP manufacturing process development in several platform technologies, including cell & gene therapy, bio-active peptides, and recombinant protein with a focus on cancer immunotherapy, angiogenesis, autoimmunity, and inflammatory diseases. Tim has held positions of increasing responsibility at Chiron (Novartis), Aventis Gencell, Sangstat (Genzyme), BD Biosciences, Progenitor Cell Therapy (Caladrius Biosciences), and Cellerant Therapeutics.
Don Klabunde, Director of Enterprise Systems & IT is a seasoned technology leader with a track record of successfully leveraging technology solutions such as ERP, CRM, E-commerce, and other business tools that increase business productivity. Mr. Klabunde is providing leadership for the implementation of a completely new enterprise software platform together with a donor management system (DMS) that will greatly enhance AllCells’ capabilities to deliver products & services, manage business workflow, and better serve customers. Don has led teams from angel startups to large fortune 500 sized companies.
Ted Parenti, Director of Accounting & Finance brings to AllCells extensive experience in cost accounting, capital investment and budget, and forecast/analysis using ERP systems. Mr. Parenti leads the company’s accounting control, financial reporting, forecasting processes, and oversees the company’s human resources. Prior to joining AllCells, Ted served as Industrial Controller with Bio-Rad Laboratories, Cost Accounting Manager with Peet’s Coffee & Tea, Cost Manager with The Clorox Company, and Regional Finance Manager with General Mills Operations.
“AllCells has committed to a stronger leadership team to enable the company to continue to execute on its growth initiatives. I’m confident these individuals, together with our current executive team consisting of Wayne Vaz-VP, Corporate Development, Lewis Chapman-VP, Global Commercial Operations, and Rob Frankenberg-VP, Manufacturing Operations, will make an immediate and substantial impact in our ongoing efforts to further increase our hematology & immunology expertise, improve the company’s business processes, and deliver exceptional value to our customers.” said Jay Tong, M.D, President & CEO.
About AllCells, LLC
AllCells is a biotechnology company dedicated to providing researchers and biomanufacturing organizations with high quality primary cells that enable drug discovery, preclinical development, and manufacturing of cell therapies. Leveraging its expertise in hematopoietic and immune cell isolation and characterization together with on-site hematologic tissue clinical collection operations, AllCells maintains a large repository of donor profiles that can be qualified for various biomedical applications. Freshly collected tissue is immediately processed in contiguous manufacturing facilities to produce purified cell types having unparalleled quality and consistency. Cells are shipped worldwide, or fresh cells can be immediately utilized in fee-for-service cell-based assays (AllCellutions™) custom designed according to customer criteria. For more information, please visit www.allcells.com.
MEDIA Contact: Wayne E. Vaz, VP, Corporate Development, AllCells, LLC, P (510) 671-8676